[Federal Register Volume 87, Number 160 (Friday, August 19, 2022)]
[Notices]
[Pages 51113-51114]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-17841]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2022-0098; NIOSH 278]


Board of Scientific Counselors, National Institute for 
Occupational Safety and Health (BSC, NIOSH)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting of the Board of Scientific Counselors, 
National Institute for Occupational Safety and Health (BSC, NIOSH). 
This meeting is open to the public via virtual meeting, limited only by 
the number of web conference lines (500 web conference lines are 
available). Time will be available for public comment.

DATES: The meeting will be held on October 4, 2022, from 10:00 a.m. to 
3:00 p.m., EDT.
    Written comments must be received on or before September 27, 2022.

ADDRESSES: If you wish to attend the meeting, please register at the 
NIOSH website at https://www.cdc.gov/niosh/bsc/ or by telephone at 
(202) 245-0649 no later than September 27, 2022.
    You may submit comments, identified by Docket No. CDC-2022-0098; 
NIOSH-278, by either of the methods listed below. Do not submit 
comments for the docket by email. CDC does not accept comments for the 
docket by email.
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Sherri Diana, NIOSH Docket Office, National 
Institute for Occupational Safety and Health, 1090 Tusculum Avenue, 
Mailstop C-34, Cincinnati, Ohio 45226. Attn: Docket No. CDC-2022-0098; 
NIOSH-278.
    Instructions: All submissions received must include the Agency name 
and Docket Number. Docket number CDC-2022-0098; NIOSH-278 will close 
September 27, 2022.

FOR FURTHER INFORMATION CONTACT: Maria Strickland, M.P.H., Designated 
Federal Officer, BSC, NIOSH, CDC, Patriots Plaza 1, 395 E Street SW, 
Suite 9200, Washington, DC 20201; Telephone: (202) 245-0649; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Secretary of Health and Human Services, the Assistant 
Secretary for Health, and by delegation the Director, Centers for 
Disease Control and Prevention, are authorized under Sections 301 and 
308 of the Public Health Service Act to conduct directly, or by grants 
or contracts, research, experiments, and demonstrations relating to 
occupational safety and health and to mine health.
    The Board of Scientific Counselors, National Institute for 
Occupational Safety and Health provides advice to the Director, 
National Institute for Occupational Safety and Health, on NIOSH 
research and prevention programs. The Board also provides guidance on 
the Institute's research activities related to developing and 
evaluating hypotheses, systematically documenting findings, and 
disseminating results. In addition, the Board evaluates the degree to 
which the activities of NIOSH: (1) conform to those standards of 
scientific excellence appropriate for federal scientific institutions 
in accomplishing objectives in occupational safety and health; (2) 
address currently relevant needs in the fields of occupational safety 
and health either alone or in conjunction with other known activities 
inside and outside of NIOSH; and (3) produce their intended results in 
addressing important research questions in occupational safety and 
health, both in terms of applicability of the research findings and 
dissemination of the findings.
    Matters To Be Considered: The agenda for the meeting addresses 
health communications, updates from the National Firefighter Registry 
Subcommittee, progress on the NIOSH Evaluation Capacity Building Plan, 
and implementation science. Agenda items are subject to change as 
priorities dictate.
    The agenda is posted on the NIOSH website at https://www.cdc.gov/niosh/bsc/.

Public Participation

    Written Public Comment: Written comments will be accepted per the 
instructions provided in the addresses section above. Comments received 
in advance of the meeting are part of the public record and are subject 
to public disclosure. They will be included in the official record of 
the meeting. Do not include any information in your comment or 
supporting materials that you consider confidential or inappropriate 
for public disclosure. If you include your name, contact information, 
or other information that identifies you in the body of your comments, 
that information will be on public display. CDC will review all 
submissions and may choose to redact, or withhold, submissions 
containing private or proprietary information such as Social Security 
numbers, medical information, inappropriate language, or duplicate/near 
duplicate examples of a mass-mail campaign. CDC will carefully consider 
all comments submitted into the docket.
    Written comments received by September 27, 2022, will be provided 
to the Board prior to the meeting.
    Oral Public Comment: The public is welcome to participate during 
the public comment period, from 1:00 p.m. to 1:15 p.m., EDT, October 4, 
2022. Each commenter will be provided up to 5 minutes for comment. A 
limited number of time slots are available and will be assigned on a 
first-come, first-served basis. Members of the public who wish to 
address the BSC, NIOSH are requested to contact the Designated Federal 
Officer for scheduling purposes (see FOR FURTHER INFORMATION CONTACT 
above).
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been

[[Page 51114]]

delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-17841 Filed 8-18-22; 8:45 am]
BILLING CODE 4163-18-P